This presentation will provide an overview of investigator-sponsored clinical trials with multiple research sites. Specifically, we will address the oversight responsibilities for multicenter clinical trials in regard to monitoring, risk management, data collection and compliance.
The presentation will also include a discussion of FDA expectations, reporting requirements, and University of Pittsburgh Office for Investigator-Sponsored IND and IDE Support (O3IS) guidance for the management of external sites.
No registration required. Submit advance questions or comments to email@example.com.
Wednesday, June 19 at 11:00 a.m. to 12:00 p.m.